Urgent Appeal from International Society for Aerosols in Medicine (ISAM) During COVID-19: Clinical Decision Makers and Governmental Agencies Should Consider the Inhaled Route of Administration: A Statement from the ISAM Regulatory and Standardization Issues Networking Group

Affiliations

• ¹ Jolyon Mitchell Inhaler Consultancy Services, Inc., London, Ontario, Canada.
• ² Pulmonology Division, Department of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock, Arkansas, USA.
• ³ ACLiRA Consulting GmbH, Ebsdorfergrund, Germany.
• ⁴ Insmed, Inc., Bridgewater, New Jersey, USA.
• ⁵ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
• ⁶ Respidex LLC, Dennis, Massachusetts, USA.
• ⁷ College of Pharmacy, University of Florida, Gainesville, Florida, USA.
• ⁸ Inspired-Pulmonary Solutions LLC, San Carlos, California, USA.
• ⁹ Faegre Drinker Biddle & Reath LLP, Washington, District of Columbia, USA.
• ¹⁰ College of Pharmacy, College of Medicine and The University of Arizona-Tucson, Tucson, Arizona, USA.
• ¹¹ Department of Medicine, UCSD, La Jolla, California, USA.
• ¹² Aerogen Pharma Corporation, San Mateo, California, USA.
• ¹³ St. Joseph's Hospital Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
• ¹⁴ Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada.
• ¹⁵ Centre Hospitalier Régional et Universitaire de Tours, Médecine Intensive Réanimation, Tours, France.
• ¹⁶ VisionRealisation, Shepshed, Leicestershire, United Kingdom.
• ¹⁷ School of Medicine, Universtiy of California San Francisco, San Francisco, California, USA.